← Back to Search

Faith-Based Physical Activity Programs for Cardiovascular Health

N/A
Recruiting
Led By Elva Arredondo, PhD
Research Sponsored by San Diego State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months post-baseline
Awards & highlights

Study Summary

This trial will test strategies to increase physical activity and reduce chronic disease in Latino churches, empowering members to make healthier lifestyle choices.

Who is the study for?
This trial is for Latina women aged 18-65 who plan to attend their church regularly for the next 18 months, engage in less than 50 minutes of moderate-to-vigorous physical activity (MVPA) per week, and have no health issues that limit physical activity. Those with cognitive impairments or other health conditions that prevent PA are excluded.Check my eligibility
What is being tested?
The study tests three versions of a program called Faith in Action aimed at increasing physical activity to prevent cardiovascular disease among Latinas. Churches will implement either the standard program, an enhanced version with tailored messaging and leader training, or an enhanced version plus strategies to help sustain the program long-term.See study design
What are the potential side effects?
Since this trial focuses on implementing physical activity programs rather than medical interventions, traditional side effects associated with medications are not applicable. However, participants may experience typical exercise-related discomforts such as muscle soreness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months post-baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months post-baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Individual Level: Change in Participants' Moderate to Vigorous Physical Activity (MVPA) from Baseline to Month 12
Individual Level: Change in Participants' Moderate to Vigorous Physical Activity (MVPA) from Baseline to Month 6
Organizational Level: Change in Innovation-Values fit from Baseline to Month 12
+1 more
Secondary outcome measures
Individual Level: Maintenance of Moderate to Vigorous Physical Activity (MVPA) at 18 months
Organizational Level: Maintenance of Promotoras' MI Calls
Organizational Level: Maintenance of Promotoras' PA Class Delivery

Trial Design

3Treatment groups
Experimental Treatment
Group I: Standard EBI ConditionExperimental Treatment1 Intervention
Faith in Action as originally implemented
Group II: Enhanced ConditionExperimental Treatment1 Intervention
Standard condition + organizational-level implementation strategies
Group III: Enhanced + Sustainment conditionExperimental Treatment1 Intervention
Enhanced implementation condition + maintenance strategies

Find a Location

Who is running the clinical trial?

San Diego State UniversityLead Sponsor
153 Previous Clinical Trials
83,521 Total Patients Enrolled
Washington University School of MedicineOTHER
1,937 Previous Clinical Trials
2,298,883 Total Patients Enrolled
University of California, BerkeleyOTHER
181 Previous Clinical Trials
720,344 Total Patients Enrolled

Media Library

Faith in Action Clinical Trial Eligibility Overview. Trial Name: NCT05473871 — N/A
Cardiovascular Disease Research Study Groups: Enhanced + Sustainment condition, Enhanced Condition, Standard EBI Condition
Cardiovascular Disease Clinical Trial 2023: Faith in Action Highlights & Side Effects. Trial Name: NCT05473871 — N/A
Faith in Action 2023 Treatment Timeline for Medical Study. Trial Name: NCT05473871 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is eligibility for this medical trial restricted to those over a certain age?

"As indicated by the study's eligibility requirements, individuals aged 18-65 are invited to join this medical trial."

Answered by AI

To whom does this medical study offer the greatest potential benefits?

"To be accepted as a participant in this cardiovascular trial, candidates must have the disease and fall within the age range of 18 to 65. A total of 812 people will be admitted into the study's cohort."

Answered by AI

Is enrollment in this experiment still available for participants?

"As per the clinicaltrials.gov listing, this medical study is in search of participants and has been active since November 15th 2022. The trial was last updated on March 20th 2023."

Answered by AI

How many participants are currently partaking in this experiment?

"Affirmative, the information from clinicaltrials.gov reveals that this medical research is actively seeking participants. This project was first announced on November 15th 2022 and most recently updated on March 20th 2023. It requires 812 individuals to be recruited at a single site."

Answered by AI
~475 spots leftby May 2026